Alterity Therapeutics Limited
ATH
Peringkat dalam Saham
#25473
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Harga Saham
$0.21511186
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$47.00M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-38.54%
Negara
AU
Perdagangan Alterity Therapeutics Limited (ATH)
Kategori
Healthcare
Kapitalisasi pasar dari Alterity Therapeutics Limited(ATH)
Kapitalisasi Pasar: $47.00M
Per October 2026, Alterity Therapeutics Limited memiliki kapitalisasi pasar sebesar $47.00M. Ini menjadikan Alterity Therapeutics Limited sebagai perusahaan 25473rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Alterity Therapeutics Limited dari 2012 hingga 2026
ATH dibandingkan dengan 5 teratas stocks paling populer
